Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$747K Sell
56,430
-3,679
-6% -$58.3K 0.01% 1144
2026
Q1
$1.03M Buy
60,109
+4,112
+7% +$76.3K 0.01% 863
2025
Q4
$1.14M Buy
55,997
+225
+0.4% +$4.88K 0.01% 750
2025
Q3
$1.31M Buy
55,772
+7,873
+16% +$158K 0.01% 720
2025
Q2
$856K Sell
47,899
-24,020
-33% -$469K 0.01% 802
2025
Q1
$1.49M Buy
71,919
+18,287
+34% +$329K 0.02% 580
2024
Q4
$634K Buy
53,632
+3,810
+8% +$47.1K 0.01% 835
2024
Q3
$607K Sell
49,822
-5,429
-10% -$45K 0.02% 833
2024
Q2
$405K Buy
55,251
+2,468
+5% +$19.5K 0.01% 1002
2024
Q1
$405K Buy
52,783
+27,258
+107% +$264K 0.01% 906
2023
Q4
$372K Buy
25,525
+3,911
+18% +$62.2K 0.01% 904
2023
Q3
$397K Buy
+21,614
New +$367K 0.01% 777

Other funds holding XPEV

Vident Advisory's XPEV Position: Q2 2026 in Review

Vident Advisory reduced its XPeng (XPEV) stake by 6.1% in Q2 2026, selling an estimated $58.3K and leaving 56,430 shares worth $747K. The position accounts for 0.01% of the portfolio, ranked #1144.

Vident Advisory first reported a position in XPEV in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.49M in Q1 2025. 221 funds tracked by Wall St. Rank hold XPEV as of Q2 2026.

  • Vident Advisory held 56,430 shares of XPeng worth $747K as of Q2 2026.
  • Vident Advisory sold 3,679 XPeng shares in Q2 2026, an estimated $58.3K.
  • XPeng made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #1144 holding.
  • Vident Advisory first reported a position in XPeng in Q3 2023 and has held it in 12 quarters since.
  • Vident Advisory's XPeng position peaked at $1.49M in Q1 2025.
  • 221 funds tracked by Wall St. Rank held XPeng as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.